Robert Suriano, Ph.D.
Affiliations: | 2007 | New York Medical College, New York, NY, United States |
Area:
ImmunologyGoogle:
"Robert Suriano"Parents
Sign in to add mentor| Raj K. Tiwari | grad student | 2007 | New York Medical College | |
| (N-glycans modulate the biochemical and biological function of tumor rejection antigen gp96.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| DeSouza NR, Nielsen KJ, Jarboe T, et al. (2024) Dysregulated Expression Patterns of Circular RNAs in Cancer: Uncovering Molecular Mechanisms and Biomarker Potential. Biomolecules. 14 |
| Reyes I, Reyes N, Suriano R, et al. (2018) Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma. Cancer Biomarkers : Section a of Disease Markers |
| Maniyar R, Chakraborty S, Suriano R. (2018) Ethanol Enhances Estrogen Mediated Angiogenesis in Breast Cancer. Journal of Cancer. 9: 3874-3885 |
| Maniyar RR, Bednarczyk RB, Rahoma GMB, et al. (2016) Abstract 3365: Provasculogenic effects of alcohol and estrogen: implications for breast cancer development Cancer Research. 76: 3365-3365 |
| Maniyar RR, Tuli N, Suriano R, et al. (2016) Abstract 2365: Checkpoint inhibitors and a multivalent melanoma vaccine as a novel combinatorial therapy Cancer Research. 76: 2365-2365 |
| Hanly EK, Tuli NY, Bednarczyk RB, et al. (2015) Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells. Oncotarget |
| George AL, Suriano R, Rajoria S, et al. (2015) PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells. Journal of Cancer. 6: 1320-1330 |
| Suriano R, Tuli N, Geliebter J, et al. (2015) Abstract A30: Small molecule kinase inhibitor mediated modulation of immunotherapy in melanoma Cancer Research. 75 |
| Suriano R, Tuli NY, Geliebter J, et al. (2015) Abstract 3540: Novel targeted combinational therapies for melanoma Cancer Research. 75: 3540-3540 |
| Hanly EK, Rajoria S, Darzynkiewicz Z, et al. (2014) Disruption of mutated BRAF signaling modulates thyroid cancer phenotype. Bmc Research Notes. 7: 187 |